Risk of second non breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving treatment

被引：0
|
作者：
不详
机构：
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：127 / 128
页数：2
相关论文
共 50 条
  • [1] Risk of breast recurrence in relation to BRCA1/2 mutation status following breast-conserving surgery and radiotherapy
    Kirova, Y. M.
    Stoppa-Lyonnet, D.
    Savignoni, A.
    Sigal-Zafrani, B.
    Clough, K. B.
    Barbier, N.
    Fourquet, A.
    EJC SUPPLEMENTS, 2004, 2 (03): : 150 - 151
  • [2] Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China
    Wei Cao
    Yuntao Xie
    Yingjian He
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Tie Fan
    Tao Ouyang
    Breast Cancer Research and Treatment, 2019, 175 : 749 - 754
  • [3] Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation
    Ye, Fugui
    Huang, Liang
    Lang, Guantian
    Hu, Xin
    Di, Genhong
    Shao, Zhimin
    Cao, Ayong
    CANCER MEDICINE, 2020, 9 (05): : 1903 - 1910
  • [4] Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China
    Cao, Wei
    Xie, Yuntao
    He, Yingjian
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Ouyang, Tao
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (03) : 749 - 754
  • [5] BRCA1/BRCA2 in breast-conserving therapy -: Reply
    Hellman, S
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3689 - 3689
  • [6] SECOND BREAST CANCER RISK IN BRCA1 AND BRCA2 MUTATION CARRIERS PATIENTS
    Palazzo, A.
    Iacovelli, R.
    Trenta, P.
    Sidoni, T.
    Ricevuto, E.
    Naso, G.
    Giannini, G.
    Gulino, A.
    Cortesi, E.
    De Marchis, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 33 - 33
  • [7] Increased risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers after breast-conserving therapy compared to mastectomy
    Schmutzler, R. K.
    Graeser, M. K.
    Rhiem, K.
    Schlehe, B.
    Hofmann, W.
    Jonat, W.
    Schoenbuchner, I.
    Kiechle-Bahat, M.
    Strunz, K.
    Engel, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Breast-conserving Therapy and the Risk of Second Primaries in BRCA1/2 Mutation Carriers
    Hallam, S.
    Govindarajulu, S.
    Huckett, R.
    Bahl, A.
    CLINICAL ONCOLOGY, 2016, 28 (03) : 225 - 225
  • [9] Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
    Emiroglu, Selman
    Ozkurt, Enver
    Cabioglu, Neslihan
    Igci, Abdullah
    Saip, Pinar
    Yazici, Hulya
    Ozmen, Tolga
    Ozmen, Vahit
    Muslumanoglu, Mahmut
    Tukenmez, Mustafa
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 163 - 173
  • [10] Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-con serving surgery and radiotherapy
    Kirova, YM
    Stoppa-Lyonnet, D
    Sigal-Zafrani, B
    Fabre, N
    Fourquet, A
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) : 2304 - 2311
12345